Followers | 212 |
Posts | 20708 |
Boards Moderated | 3 |
Alias Born | 01/09/2019 |
![](https://investorshub.advfn.com/uicon/697925.png?cb=1685037577)
Thursday, September 03, 2020 7:18:29 PM
I have been burnt by a lot of posters lying to me on Ihub through the years. But I have learned who to trust after learning the hard way. But when the selling started on Tuesday, my natural inclination was to get nervous and sell. Why? Because I start thinking I am getting scammed again and then consternation sets in! Do you sell or not sell? I HELD AND DIDN'T SELL (except carving out my freebies last week)!
So why didn't I freak and sell? BECAUSE I AM NOW 100% SURE WHAT I OWN. Even after reading PACER docs the last week or so, I still had doubt. My apprehensive self said the p and d crew must be in cohorts with AUCTUS so they can make a lot of money. Then Auctus can buy and make money too to help erase their losses etc. So imaginary stories like that played out in my head.
Simply, I was WRONG WRONG WRONG TO DOUBT! This whole restructuring is MUCH bigger than Ihub. It is much bigger than anyone here. I am done doubting why the IP is worth a crap load now vs. why it wasn't 2-3 months ago or why no one came to outbid Desmarais before Auctus stepped in. I don't have to worry who the buyers will be when the 10th comes or thereafter anymore.
Why again? BECAUSE I KNOW WHAT I OWN. This used to be any other NASDAQ Biomed company with promise like a lot of them, but they simply ran out of money. That is what happened here. Auctus isn't doing this to keep themselves busy, they are doing it because they KNOW the VALUE of the patents and the IP with it soon to be heading into phase III. THIS STOCK USED TO BE A LOT HIGHER ON A REVERSE SPLIT ADJUSTED BASIS. WHY? Biomed funds saw value too! Why didn't they outbid Desmarais you still may ask? Because they don't have time for restructuring and want to invest when it is back on the SILVER platter for them! (There is one of your buyers!)
We know this: Bankruptcy restructuring plays are almost ALWAYS HOME RUNS! Careful now, that is in the short term though. It may only last a year and Auctus may have to cut ties. But the buyers will come. Trust me because I finally trust myself. Stop selling. You are going to miss the big run!
This reorganization is a gift to us! Don't trade it or you may miss out! Yes, take gains to own freebies like i did if you can but own it and then sell it in a week or two or two months from now. Otherwise, you may miss one of the easiest orchestrated profits to fall into your lap in OTC history!
This of course is all my KNOWN opinion! The light is finally shining! Trust the process.
Recent BRTX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:11:03 PM
- BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/13/2024 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/08/2024 08:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:47:26 PM
- BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine • GlobeNewswire Inc. • 07/23/2024 11:10:00 AM
- BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/27/2024 11:40:00 AM
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM